For the pig respiratory tract pathogens, Actinobacillus pleuropneumoniae and Pasteurella multocida, Minimum Inhibitory Concentration (MIC) of marbofloxacin was determined in recommended broths and pig serum at three inoculum strengths. MICs in both growth matrices increased progressively from low, through medium to high starting inoculum counts, 10 4 , 10 6 and 10 8 CFU/mL, respectively. P. multocida MIC ratios for high:low inocula were 14:4:1 for broth and 28.2:1 for serum. Corresponding MIC ratios for A. pleuropneumoniae were lower, 4.1:1 (broth) and 9.2:1 (serum). MIC high:low ratios were therefore both growth matrix and bacterial species dependent. The effect of alterations to the chemical composition of broths and serum on MIC were also investigated. Neither adjusting broth or serum pH in six increments over the range 7.0 to 8.0 nor increasing calcium and magnesium concentrations of broth in seven incremental steps significantly affected MICs for either organism. In time-kill studies, the killing action of marbofloxacin had the characteristics of concentration dependency against both organisms in both growth matrices. It is concluded that MIC and time-kill data for marbofloxacin, generated in serum, might be preferable to broth data, for predicting dosages of marbofloxacin for clinical use.
Introduction
The most widely used parameter of antimicrobial drug potency is Minimum Inhibitory Concentration (MIC). This is the lowest (fixed) drug concentration which inhibits bacterial growth in vitro under standard conditions, after incubation for a fixed time. Guidelines and standards have been set by the European Union Committee on Antimicrobial Sensitivity testing (EUCAST) and the Clinical Laboratory Standards Institute (CLSI). Their methods require use of a specific broth for each organism (formulated to facilitate /optimise bacterial growth) and are conducted using two-fold dilutions. Each test incorporates control organisms of known MIC. The adoption of CLSI and EUCAST guidelines and standards ensures that data generated is consistent between individual experimenters, between laboratories and across countries (Papich 2013) . From a clinical use perspective, the principal objective in generating MIC data for each drug against each pathogenic organism harvested from each animal species is its application to determine dosage regimens that optimise bacterial kill and minimise opportunities for the emergence of resistance. For this purpose the following considerations are paramount:
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4 µg/mL; from dose determination perspectives it is accuracy rather than which is required;
 MICs provide a measure of potency for a fixed concentration over a fixed time period, whereas in clinical use drug concretions decrease steadily after intravenous administration or increase to a maximum and then decrease, as absorption is balanced by elimination after non-vascular dosing;
 MIC gives no indication of the time course of killing action , which may be concentration-, time-or co-dependent and this killing pattern may differ for a single drug against differing microbial species;
 MIC is determined using a fixed inoculum count of 5x10 5 CFU/mL under EUCAST and CLSI guidelines, whilst bacterial load, on which rate and extent of bacterial kill is likely to depend, may be much higher or lower and vary with time in vivo;
 in vivo, in diseased but immunocompetent animals, bacteriological cure will be assisted by natural body defences.
To partially address the above considerations, in relation to correlating pharmacokinetic and pharmacodynamic data to predict dosages, we have used five sets of overlapping two-fold dilutions in previous studies; this reduces the inaccuracy from approaching 100% to not exceeding 20% (Aliabadi and Lees, 2001; Sidhu et al., 2010) . Also, to enable comparisons between broth and biological fluids, as growth matrices for bacteria, and to evaluate possible differences between them, previous studies have been undertaken in serum, plasma and inflammatory exudate Lees, 2001, 2002; Nightingale and Murakawa 2002; Zeitlinger et al., 2004 Zeitlinger et al., , 2008 Zeitlinger et al., , 2011 Sidhu et al., 2010) . A future development might be
generation of MIC data in biophase fluids, which might be serum, urine (of varying pH), milk, prostate and pulmonary epithelial lining fluid etc., For some drug classes, potency differences between broths and biological fluids are small and have no significant impact on dose prediction; provided the inactive protein bound plasma/serum drug concentration is known and corrected for. For other drug classes, however, differences between broths and biological fluids may be large. In a recent study, several tetracyclines were compared for MICs in broth and 50% broth:50% mouse serum as matrices (Honeyman et al., 2015) . For a strain of Strep. pneumoniae, MICs were identical for five compounds but, with added serum, 2-4 fold increases were obtained for five further compounds, and MIC was increased 32-fold for one compound. In contrast, for a strain of Staph. aureus, MIC was increased in the broth:serum combined matrix relative to broth for all 12 compounds investigated and for seven the increase was in the range 8-128-fold.
Likewise, Brentnall et al. (2012) 
Materials and Methods

Bacterial isolates
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7 glycerol in sterile distilled water. The mixture was sterilized by boiling for 5sec, left to cool for 12h and then boiled again for a further 5sec.
Six isolates of each species were selected, based on three criteria: (1) ability to grow logarithmically in both CLSI recommended broth and pig serum; (2) susceptibility to marbofloxacin, as indicated by MIC determined using two-fold dilutions; and (3) then, selection of isolates with the highest and lowest broth MICs plus four randomly selected isolates with intermediate MICs. This pre-selection procedure ensured that all isolates could be used in further MIC and time-ill investigations in broth and serum.
Culture methods and bacterial counts
For A. pleuropneumoniae, Chocolate Mueller Hinton Agar (CMHA) was used for growth on a solid medium and Columbia broth supplemented with 2µg/mL nicotinamide adenine dinucleotide (NAD) was the liquid broth. This was selected in preference to veterinary fastidious medium (VFM) as it was consistently better at supporting bacterial growth and without the formation of blood pellets in VFM determination of MIC endpoint was easier for user. Mueller Hinton agar supplemented with 5% defibrinated sheep blood (MHA) was used to grow P. multocida and the liquid medium was CAMHB. Organisms were incubated in a static incubator at 37 o C for 18-24 h.
Bacterial counts were determined by serial dilution and spot plate counts. Ten-fold or 100-fold dilutions were carried out in Phosphate Buffered Saline. Three 10µL drops of the appropriate dilutions were dropped onto the agar surface and allowed to dry for 10min before incubating. After 24 h incubation, the mean CFU count for each 10µL was determined, multiplied by 100 and then multiplied by the dilution factor to obtain the original CFU/mL.
Minimum Inhibitory Concentrations
MICs were determined by microdilution for six isolates each of A. pleuropneumoniae and P.
multocida, in accordance with CLSI guidelines, except for (1) using five sets of overlapping two-fold serial dilutions to reduce inaccuracy of individual isolate estimates from up to 100%
to not greater than 20%; (2) comparing serum with broth; (3) using Columbia broth supplemented with 2µg/mL nicotinamide adenine dinucleotide (NAD) as the liquid broth;
and (4) use of starting inocula of three strengths. These were high (1.5.10 8 CFU/mL), medium (1.5.10 6 CFU/mL) and low (1.5.10 4 CFU/mL). A 0.5 McFarland standard was made to provide a count of 1.5x10 8 CFU/mL (high). Two 1:10 dilutions provided a count of 1.5x10 6 CFU/mL (medium). Two further 1:10 dilutions gave counts of 1.5x10 4 CFU/mL (low). MICs were determined in broth and serum, for six isolates of each species, triplicate estimates per isolates.
Marbofloxacin, media and culture were added successively to each well of 96-well plates and plates sealed and incubated statically at 37 o C for 24h. Spot plate counts were prepared immediately after plate inoculation. Tests on each isolate were undertaken in triplicate.
Control ATCC isolates were used at a count of 5x10 5 CFU/mL as per CLSI guidelines. A positive control well contained medium and pathogen only and a negative control contained medium and marbofloxacin solution. Blank controls contained medium only.
Effect of varying pH and divalent cation concentrations on MIC
Studies were conducted on two isolates each of P. multocida and A. pleuropneumoniae to investigate the influence on MIC of: (1) varying inoculum pH (broth and serum); (2) increased concentrations of Ca ++ and Mg ++ (broth). To determine the effect of pH on MIC, the starting pH was adjusted to 7.0, 7.2, 7.4, 7.6, 7.8 or 8.0, using hydrochloric acid (1M) or sodium hydroxide (1M). . This test was repeated for P. multocida and A.
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pleuropneumoniae, although it is noted that CAMHB is not the recommended broth for A.
pleuropneumoniae.
Time-kill curves
Time-kill curves were generated for six isolates each of A. pleuropneumoniae and P. multocida in both broth and serum. Two to 3 colonies of each isolate were added to 5 mL broth or serum and incubated overnight in an orbital incubator. Fifty µL of culture were diluted 1:50 in pre-warmed broth or serum and incubated statically for 1 h at 37 o C. This was compared to a 0.5 McFarland Standard and diluted ten-fold to obtain the starting inoculum, consistent with MIC determinations, at 2x10 7 CFU/mL, and confirmed by colony counts.
Concentrations comprising eight multiples of MIC (0.25, 0.5, 1, 1.5, 2, 4, 6 and 8x) were prepared in pre-warmed broth or serum. Ten µL of culture were used to inoculate the dilutions to give a 1 mL final volume.
Fifty µL of each culture were sampled and viability determined through serial dilution and spot plates at nine time points; 0, 0.25, 0.5, 0.75, 1, 2, 4, 8 and 24h. No organism was added as a negative control, whereas in positive controls no drug was added. Spot plates were examined for contamination and biochemical identification methods were applied for suspect colonies. Measurements were conducted in triplicate for six isolates of both organisms in broth and serum. The lower limit of quantification (LLOQ) was 33CFU/mL.
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Data analysis
Data were recorded on Microsoft excel, processed using GraphPad Prism v6 and analysed using IBM SPSS Statistics 22 by Kruskal-wallis H with post-hoc Mann-Whitney U test.
Results
Influence of inoculum count on MIC
MICs were inoculum size dependent for both organisms, increasing progressively with inoculum count, in both media (Tables 1 and 2 ). For P. multocida, MIC ratios high:low inocula were significant (P<0.001) for broth (14.4:1) and serum (28.2:1). Ratios high:medium inocula were also significant for both media, 7.21:1 (broth) and 11.2:1 (serum) (P<0.01). For
A. pleuropneumoniae high:low inocula ratios were somewhat lower but also statistically significant (P<0.01) for broth (4.1:1) and serum (9.2:1). Ratios high:medium inocula were also significant for both media.
The data revealed a second important effect of initial inoculum load on MICs. The serum:broth MIC ratio was higher for the high inoculum count (1.23:1) than for the low starting count for which the ratio was 0.63:1.
Influence of pH and cation concentrations on MIC
Alteration of pH over the range 7.0 to 8.0, in six increments, did not affect MICs for either P. multocida ( Fig.1) or A. pleuropneumoniae (Fig.2) in either broth or serum. In broth, increasing concentrations of Ca ++ and Mg ++ likewise did not significantly affect MICs for either organism (Fig.3) .
Time-kill curves
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Time-kill curves for eight multiples of MIC for six isolates of each species are illustrated in
Figs. 1 (P. multocida) and 2 (A. pleuropneumoniae). For P.multocida, there was progressive growth inhibition at 1.5 and 2xMIC in both media; 2xMIC produced a 3log 10 decrease in CFU/mL by 2-4 h. In broth, concentrations at and above 4xMIC resulted in virtual eradication at 8h, and at 8xMIC by 24 h in serum. For A. pleuropneumoniae, the patterns of growth inhibition were very similar for both media; little inhibition occurred at concentrations less that 1xMIC but 4xMIC produced a 3-4log 10 decrease in CFU/mL by 8 h in both media. Virtual eradication (< 33 CFU/mL) occurred in both media at 6xMIC by 8 h and at 8xMIC by 4 h. For both organisms, the action of marbofloxacin in both media was classed as concentration-dependent.
Discussion
A previous study from this laboratory reported no significant differences in MIC between broths and pig serum for the pig pneumonia pathogens, P. multocida and A.
pleuropneumoniae (Dorey et al., submitted) . However, when serum MICs were corrected for drug binding to serum protein, to allow for the fact that protein bound drugs are microbiologically inactive (Wise, 1986 , Zeitlinger, 2011 , Gonzalez, 2013 ) the unbound fraction MIC was approximately 0.5X the broth MIC. This finding indicated that potency was approximately twice as high (MIC lower) in serum compared with broth and therefore that correction for protein binding is necessary but not sufficient. The data suggested that biological fluids such as serum might be more suitable for PK/PD integration and modelling procedures for predicting optimal doses, for example through establishing PK/PD breakpoints.
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In addition to protein binding, Zeitlinger et al. (2008) described another factor potentially accounting for differences in MIC between broths and serum, namely differing bacterial growth rates. They compared growth curves, in the absence of antimicrobial drugs, for
Staphylococcus aureus and Pseudomonas aeruginosa in MHB, serum and varying proportions of serum admixed with MHB. For both species, logarithmic growth was slower in serum than broth. This might provide more rapid kill in serum for a given drug concentration, as a consequence of a lesser microbial challenge. Slower growth rates in pig serum compared to broth for P. multocida and A. pleuropneumoniae were obtained for both species in pig serum compared to broth in our laboratory (Dorey et al., unpublished data) .
The above findings stimulated further research, now published in this article. It was clearly established that a high inoculum count (10 8 CFU/mL) increased broth MIC by some 14-fold for P. multocida compared to a low count of 10 4 CFU/mL. Whilst differences might well be predictable, it is important to establish the magnitude of differences, if (as we intend) the data is to be used in PK/PD breakpoint and dose prediction studies for differing pathological loads. Moreover, the difference was growth matrix dependent; the corresponding high:low ratio for serum MIC was 28-fold greater. This matrix dependency lends further weight to the rationale for conducting MIC studies in biological fluids rather than broths for the purpose of determining PK/PD breakpoints. Qualitatively, similar findings were obtained for A.
pleuropneumoniae but quantitatively they were smaller; thus, high:low MIC ratios were 4.1:1 (broth) and 9.2:1 (serum).
As a further aspect of the data, illustrating the complexity of the interactions between load and matrix, one might note the serum/broth MIC ratios. These differed, depending on inoculum load. For both pathogens, the serum:broth MIC ratio was 1.23:1 for the high inoculum load and corresponding values for the low load were 0.63:1 (P. multocida) and o 0.55:1 (A. pleuropneumoniae).
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In light of the above findings, the present study investigated two of many possible factors affecting MICs, in addition to inoculum load and logarithmic growth rate. For some drug classes (e.g. macrolides/triamilides) there is high pH dependency (Toutain et al., 2016) and for tetracyclines the potential for covalent binding to calcium and/or magnesium ions has been reported (Carlotti et al. (2012) . Korz et al. (1995) suggested that microbial growth might be limited by acidic growth conditions. In the present study, the growth medium became slightly more acidic during the logarithmic growth phase for both broth and serum (data not shown). In this study, however, altering pH in increments of 0.2 units between pHs 7.0 and 8.0 did not affect MIC for either organism and both growth matrices. Likewise, increasing in combination broth concentrations of Ca ++ and Mg ++ incrementally did not alter MICs.
Finally, our data illustrate the importance of establishing not only the potency of drugs in MIC studies which use, under EUCAST and CLSI guidelines, exposure to constant concentrations for fixed time periods and a single inoculum count in non-biological fluids, but also the potency in biological fluids and the time course of killing action. For marbofloxaxin, against the two pathogens studied, this was shown to be concentrationdependent in serum as well as broth. Time courses of kill were similar but not identical and by 24 h, in both matrices at 2xMIC, 3.5-4log 10 reductions in bacterial count had occurred. In future studies it would be relevant to extend these findings by evaluating level of kill at 48h
and 72h and also rates of kill at even higher multiples of MIC (Mitchell et al. 2012) . These investigations should now be extended to establish drug efficacy and potency with varying concentrations over time using, for example, hollow fibre infection models.
In summary, the present data suggest that MIC values should be considered on drug-by-drug, matrix-by matrix, species-by-species and load-by-load bases, not only to allow for the inactive protein bound fraction but also to allow for the many in vitro differences that can be
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14 applied, in combination with drug pharmacokinetics to prediction of dosage for use in disease models and then clinical trials.
Summary
Small but significant growth matrix dependent effects on MIC, MBC and MPCs were demonstrated for marbofloxacin for two pathogenic bacterial species harvested from pigs,
A.pleuropneumoniae and P.multocida. For these indices of potency, correction of MIC serum data for drug protein binding revealed significant differences, whereby the active concentration (unbound serum concentration) was 2-fold lower than predicted, indicating that correction for drug binding to serum protein is necessary but not sufficient. For both growth media, the use of five overlapping sets of two-fold dilutions increased the accuracy of determinations. For A.pleuropneumoniae and P.multocida, serum MPCs were 17-19 folds higher than MICs. Marbofloxacin was concentration-dependent in its killing action against both pathogens.
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